{"schema_version":"secwatch.filing_event.v1","accession":"0001720420-25-000002","form_type":"8-K","ticker":"IBEX","cik":"0001720420","company_name":"IBEX Ltd","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.580666+00:00","generated_at":"2026-05-28T10:59:46.835100+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"IBEX appoints Karen Batungbacal to board; Shuja Keen retires","bullets":["Karen Batungbacal appointed independent director, effective Jan 20, 2025; brings CX expertise from JPMorgan Chase, UnitedHealth Group.","Shuja Keen retired from board Dec 31, 2024; to advise on AI initiatives via AI Advisory Committee.","Five TRGI-designated directors (Dechant, Ballou-Aares, Zhuang, McGinnis, Jones) reappointed after TRGI revocation; board now has eight directors, five independent."],"urls":{"canonical":"https://secwatch.observer/filing/0001720420-25-000002","json":"https://secwatch.observer/filing/0001720420-25-000002.json","markdown":"https://secwatch.observer/filing/0001720420-25-000002.md","text":"https://secwatch.observer/filing/0001720420-25-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/ibex-20241231.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T10:59:46.835100+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08bea927e3","claim":"Karen Batungbacal was appointed as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, the Board appointed Karen Batungbacal as a director of the Company, effective January 20, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"0a32eb76e0","claim":"Mingzhe (JJ) Zhuang was appointed as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, the Board determined it to be in the best interests of the Company to appoint each of the Continuing Directors, effective December 31, 2024, to fill the resulting vacancies until the next annual general meeting or until their successors are elected or appointed or their office is otherwise vacated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3123930747","claim":"Patrick McGinnis was appointed as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, the Board determined it to be in the best interests of the Company to appoint each of the Continuing Directors, effective December 31, 2024, to fill the resulting vacancies until the next annual general meeting or until their successors are elected or appointed or their office is otherwise vacated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5d595e476d","claim":"Shuja Keen resigned as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, Shuja Keen informed IBEX Limited (the “Company”) that, pursuant to the terms and conditions of a purchase agreement, dated as of November 19, 2024 (the “Agreement”), between the Company and The Resource Group International Limited (“TRGI”), he intended to resign from the Company’s Board of Directors (the “Board”), including the Compensation Committee and Nominating and Governance Committee thereof, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c3c7fed1a2","claim":"Daniella Ballou-Aares was appointed as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, the Board determined it to be in the best interests of the Company to appoint each of the Continuing Directors, effective December 31, 2024, to fill the resulting vacancies until the next annual general meeting or until their successors are elected or appointed or their office is otherwise vacated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"dc7b601874","claim":"Robert Dechant was appointed as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, the Board determined it to be in the best interests of the Company to appoint each of the Continuing Directors, effective December 31, 2024, to fill the resulting vacancies until the next annual general meeting or until their successors are elected or appointed or their office is otherwise vacated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f97fdc8d91","claim":"John Jones was appointed as Director at IBEX Ltd.","evidence_excerpt":"On December 31, 2024, the Board determined it to be in the best interests of the Company to appoint each of the Continuing Directors, effective December 31, 2024, to fill the resulting vacancies until the next annual general meeting or until their successors are elected or appointed or their office is otherwise vacated.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1720420/000172042025000002/0001720420-25-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}